Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholecalciferol and muscle strength in hemodialysis patients: results from the randomized VITADIAL trial.

Clinical kidney journal·2026
Same author

Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis.

PloS one·2026
Same author

Water Consumption and Chronic Hemodialysis Therapy: Where Do We Stand? Where Must We Go? Review of Clinical Practices.

Nephron·2026
Same author

High level of infection-related hospitalizations in the 2019-2020 French national dialysis cohort.

Clinical kidney journal·2025
Same author

Being autonomous in dialysis: association with occupational status, social activity level, quality of life, and physical activity level.

Nephrologie & therapeutique·2025
Same author

Volume and Body Composition in Hemodialysis Patients: A Bioimpedance Study Assessing Differences by Sex.

Kidney medicine·2024

Related Experiment Video

Updated: Jun 23, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
09:57

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

[An efficient strategy to decrease the central venous catheter-related adverse events rate in haemodialysis

Guillaume Jean1, Thierry Vanel, Eric Bresson

  • 1Centre de rein artificiel, 42, avenue du 8-Mai-1945, 69160 Tassin-La-Demi-Lune, France. guillaume-jean-crat@wanadoo.fr

Nephrologie & Therapeutique
|April 24, 2009
PubMed
Summary

Catheter-related adverse events (CAE) significantly decreased by 50% over 10 years. Implementing newer catheter devices and switching from povidone iodine to chlorhexidine for dressing reduced CAE and associated infections.

Related Experiment Videos

Last Updated: Jun 23, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
09:57

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Medical Devices

Background:

  • Catheter-related adverse events (CAE) are a significant cause of patient morbidity and mortality.
  • Tunnelled catheters are crucial for hemodialysis access, but prone to complications.

Purpose of the Study:

  • To compare the prevalence of CAE and associated adverse events over a 10-year period.
  • To evaluate the impact of different catheter devices and antiseptic procedures on CAE rates.

Main Methods:

  • A retrospective analysis comparing two 3-year periods (1994-1997 and 2004-2007).
  • Data collected included CAE prevalence, catheter-related bacteraemia (CRB), catheter local infection (CLI), catheter dysfunction, and thrombolytic use.
  • Changes in catheter types and antiseptic skin preparation (povidone iodine vs. chlorhexidine) were key variables.

Main Results:

  • CAE prevalence decreased from 15-18% to 9-6%.
  • CRB rates dropped from 1.1 to 0.23/1000 catheter-days (p<0.001), and CLI from 1.1 to 0.28/1000 catheter-days (p<0.001).
  • Catheter dysfunction decreased from 12% to 1.2% (p<0.001), and spontaneous pulling up reduced from 4% to 0%.

Conclusions:

  • A significant reduction in CAE prevalence and related adverse events was observed over the 10-year study period.
  • The adoption of newer catheter devices and the use of chlorhexidine for skin antisepsis were associated with improved patient outcomes.